Customer Newsletter
Issue 1/09
Welcome to the NextPharma Newsletter
It was a pleasure to meet so many of you at our stand at Pharmapack in Paris last week and to have to opportunity to discuss your outsourcing needs in detail. To those of you who couldn't attend here are some of the highlights from our exhibition this year!
We have doubled our Cephalosporin packaging capacity to 18 million blisters per year at our Göttingen site in Germany - with the installation of a second flexible Alu/Alu blister-line which can also produce Alu/PVC/PVDC-blisters. This machine provides currently nine different blister Alu/Alu and Alu/PVC blisters sizes and 54 different blister formats, it also benefits from having the newest control units and a data matrix station for printing and saving pack serial numbers.
Our new partnership with Aseptic Technologies now allows us to offer our clients the benefits of closed vial technology. We have significantly expanded our Clinical Trials Manufacturing, Labeling and Packaging facility in Göttingen, Germany and our recently completed Sterile Product Development Center in Braine-l’Alleud, Belgium now enables us to offer specialist asceptic packaging and labelling to our clients for both Cytotoxic and non-Cytotoxic clinical trials’ materials.
For further information on all of our packaging and manufacturing capabilities please visit our website on www.nextpharma.com or speak to a member of our team - please call the numbers below.
With kind regards,
Your NextPharma team
Packaging Capabilities
Effective packaging is a strategic part of NextPharma's global proposition
- Alu-alu blister pack under special humidity and temperature conditions.
- Sachets under special humidity and temperature conditions.
- Packaging different blisters (including booklet) in one folded box.
- NextPharma can offer individual labelling and final packing of re-packed patches for conventional and special drug products including controlled substances.
Clinical Trials Packaging and Labelling
Primary packaging
- Primary packaging with nitrogen cover gas
- Bottle filling (HDPE, Glass)
- Blister packaging (PVC/PVDC/Alu-Alu/COC, Aclar)
- Sachet filling
Secondary packaging
- Blister cards by hot seal procedure
- Carton boxes in accordance with customers' requirements
- Dedicated suite for secondary packaging for high potent drugs
Special label design & printing
- Booklet labels
- Tear-off labels
SPDC Packaging Capabilities
Cytotoxic and Biological
- Vials
- Pre-filled syringes
- Clinical trial supplies labeling and packaging
Conventional
- Vials
- Pre-filled syringes
- Plastic and glass bottles
- Clinical trial supplies labeling and packaging
'Closed Vial' Technology
NextPharma has entered into a partnership agreement with Aseptic Technologies to manufacture sterile products using a new 'closed vial' technology. Under this agreement NextPharma will subcontract the filling of vials to Aseptic Technologies for those NextPharma customers wishing to access this new technology - which involves the aseptic filling of vials, based on a completely closed system and using pre-sterilised plastic vials. NextPharma will continue to provide other services, including overall project management, directly to customers.
The Crystal® Closed Vial Technology consists of a sterile closed plastic vial – which is sterilised by gamma irradiation and filled with a needle that pierces the stopper for liquid delivery and re-sealed by a laser shot to restore closure integrity.
The key advantages of this revolutionary system are:
- Increased safety in production, supply chain, for the medical community and the patient.
- Better sterility assurance levels, resistant to breakage and with reduced risk of spillage and leakages.
- Cost effectiveness as a result of the need for reduced production space and simplified cleaning and validation processes.
- Facilitated manipulation by end users in the medical community.
Conventional Packaging Capabilities
- Blister packs (PVC/PVDC/PP/COC/Aclar/ALU-ALU foils)
- Tubes for chewable and effervescent tablets
- Sachets (up to 2 formulations in 1 sachet)
- Glass or plastic bottles for dry syrup
- Glass or plastic bottles for tablets/capsules
- Tamper proof closures
- Carton boxes (secondary packaging)
Dedicated solids - hormones or betalactams
- Blister packs (PVC/PVDC/PP/COC/Aclar/ALU-ALU foils)
- Flow packs (Blister in alu sachets)
- Sachets
- Glass or plastic bottles for tablets/capsules
- Tamper proof closures
- Carton boxes (secondary packaging)
Liquids
Sterile (filled and terminal sterilisation):
- Vials, ampoules and cartridges in solution and lyophilized
- Eye drops
Conventionals:
- Filling, labelling and cartoning of solutions, emulsions and suspensions in glass or plastic bottles and drinkable ampoules (double point ampoules)
- Tamper proof closures
- Spray pumps and measuring devices
Semi-solids
- Filling and cartoning of gels, creams and ointments in aluminium, plastic tubes and stick packs
- Cartoning of suppositories and ovula
Manufacturing Capabilities
Significant capabilities in specialist pharmaceutical technologies
To meet our customers' needs NextPharma has established significant capabilities in specialist pharmaceutical technologies such as lyophilization, sterile fill finish and pellet technologies and also in specialist product areas such as cytotoxics, hormones, penicillins, cephalosporins and controlled substances as well as conventional dosage forms.
By providing high levels of customer services and quality, accurate documentation and delivery on time, NextPharma allows you to manage your supply chain efficiently. Our scale of operations enables us to provide a wide variety of products in batch sizes to meet your needs and readily supply markets around the world.
Qualified Person Services
For those customers wishing to import products into Europe, we offer qualified person services in conjunction with any required analytical testing.
